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Introduction
Adult skeletal muscle possesses extraordinary regeneration   
capabilities. After exercise or muscle injury, large numbers of   
new muscle fibers are normally formed within a week because of 
expansion and differentiation of muscle satellite cells (Chargé 
and Rudnicki, 2004). Satellite cells are a small population of 
myogenic stem cells for muscle regeneration, which are nor-
mally mitotically quiescent. After injury, satellite cells initiate 
proliferation to produce myogenic precursor cells, or myo-
blasts, to mediate the regeneration of muscle (Collins, 2006). 
The myoblasts undergo multiple rounds of cell division before 
terminal differentiation and formation of multinucleated myo-
tubes by cell fusion.
During  muscle  development,  somite-derived  myoblasts 
differentiate into multinucleated skeletal muscle fibers. Myo-
blasts that fail to form muscle fibers initiate apoptosis and are 
rapidly lost (Asakura and Tapscott, 1998; Borycki et al., 1999; 
Kassar-Duchossoy et al., 2005; Relaix et al., 2005; Schwartz   
et al., 2009). The state of myogenic differentiation influences 
the propensity of myoblasts to undergo apoptosis (Walsh, 1997). 
The coordinated regulation of cell proliferation, differentiation, 
and apoptosis is necessary to control the deposition of muscle 
mass during myogenesis. Recent work demonstrates that the 
molecules regulating the apoptosis cascade, such as caspase-3 
and caspase-8, are also involved in differentiation and syncytial 
fusion in both skeletal muscle fibers and placental villous 
trophoblast (Fidziańska and Goebel, 1991; Huppertz et al., 
2001; Dee et al., 2002; Fernando et al., 2002). However, it   
remains to be elucidated how molecular events select terminal 
differentiation or apoptosis during myogenesis.
MyoD is a myogenic basic helix-loop-helix transcription 
factor that plays essential roles in satellite cell activation, prolifera-
tion, and differentiation (Sabourin et al., 1999; Cornelison et al., 
2000; Asakura et al., 2007). Satellite cell–derived myoblasts iso-
lated from adult mice lacking the MyoD gene (MyoD
/) display   
accelerated growth rates, delayed terminal differentiation, and de-
layed muscle regeneration (Megeney et al., 1996; Sabourin et al.,   
1999; Cornelison et al., 2000; White et al., 2000). Recently, 
T
he molecules that regulate the apoptosis cascade are 
also involved in differentiation and syncytial fusion 
in skeletal muscle. MyoD is a myogenic transcription 
factor that plays essential roles in muscle differentiation. 
We noticed that MyoD
/ myoblasts display remark-
able resistance to apoptosis by down-regulation of miR-1   
(microRNA-1) and miR-206 and by up-regulation of Pax3. 
This resulted in transcriptional activation of antiapoptotic 
factors Bcl-2 and Bcl-xL. Forced MyoD expression induces 
up-regulation of miR-1 and miR-206 and down-regulation 
of Pax3, Bcl-2, and Bcl-xL along with increased apoptosis 
in MyoD
/ myoblasts. In contrast, MyoD gene knock-
down increases cell survival of wild-type myoblasts. The 
3 untranslated region of Pax3 mRNA contains two con-
served miR-1/miR-206–binding sites, which are required 
for targeting of these microRNAs (miRNAs). Therefore, 
these data suggest that MyoD not only regulates termi-
nal  differentiation  but  also  apoptosis  through  miRNA- 
mediated down-regulation of Pax3. Finally, MyoD, miR-1, 
and miR-206 are all down-regulated in quiescent satellite 
cells, which may be required for maintenance of muscle 
stem cells.
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Next, we examined whether MyoD expression could   
induce apoptosis. Infection with a lentivirus vector expressing 
MyoD effectively rescued MyoD protein expression in MyoD
/ 
myoblasts, detected by Western blotting and immunostaining 
(Fig. S2, B and C). More than 90% of MyoD
/ myoblasts 
became MyoD positive after infection. Ectopic expression of 
MyoD in MyoD
/ myoblasts resulted in induction of myosin 
heavy chain (MHC)–positive muscle differentiation, indicating 
that MyoD protein transduced by the lentivirus vector was func-
tional (Fig. S2 C). Differentiation conditions, UV exposure, and 
thapsigargin treatment led to much higher caspase-3 activity 
(at day 4; 3.6-fold, 14.5-fold, and 9.0-fold, respectively) when 
MyoD was expressed in MyoD
/ myoblasts as compared with 
control MyoD
/ myoblasts (Fig. 2, B and C).
To examine whether acute loss of MyoD was sufficient to 
protect against apoptosis in wild-type myoblasts, we created 
MyoD knockdown (KD) myoblasts through infection with a 
lentivirus vector expressing short hairpin RNA (shRNA) for 
MyoD. MyoD KD wild-type myoblasts showed >80% reduc-
tion in MyoD protein expression compared with the control 
myoblasts, as judged by immunostaining and Western blotting 
(Fig. S2, D–F). Importantly, under differentiation condition or after   
UV exposure or thapsigargin treatment, cell death and caspase-3 
activity were partially suppressed in MyoD KD myoblasts com-
pared with the control myoblasts (Fig. 2, D and E). Collectively, 
the ectopic expression of MyoD and MyoD KD experiments 
strongly suggest that MyoD regulates the apoptosis cascade as 
a proapoptotic factor during muscle differentiation.
MyoD suppresses antiapoptotic genes  
Bcl-2, Bcl-xL, and Pax3
To  reveal  the  molecular  cascade  of  apoptosis  regulated  by 
MyoD, we examined antiapoptotic and proapoptotic gene ex-
pression (Kuwana and Newmeyer, 2003) in wild-type versus 
MyoD
/ myoblasts by semiquantitative RT-PCR and Western 
blotting. Among antiapoptotic Bcl-2 family genes, we noticed 
that MyoD
/ myoblasts markedly up-regulated gene and protein 
expression of Bcl-2 and Bcl-xL in control growth medium and 
after UV exposure and treatment with thapsigargin (Figs. 3 A,   
4 A, and S3 A). In addition, some proapoptotic protein gene 
expression, such as Bim and Noxa, were slightly decreased in 
MyoD
/ myoblasts. Therefore, the altered antiapoptotic and 
proapoptotic protein expression may cause resistance to apop-
tosis in MyoD
/ myoblasts. It is well known that both Bcl-2 
and Bcl-xL prevent the release of proteins such as cytochrome c  
(Cyt c), an activator for caspase protease, from the mitochon-
dria (Kuwana and Newmeyer, 2003). We found that after UV 
exposure and treatment with thapsigargin, wild-type myoblasts 
induced the cytoplasmic translocation of Cyt c (Fig. 3 A). In con-
trast, MyoD
/ myoblasts failed to release Cyt c, whereas ec-
topic expression of MyoD in MyoD
/ myoblasts induced the 
cytoplasmic translocation of Cyt c (Fig. 3 B). In addition, MyoD 
KD in wild-type myoblasts decreased cytoplasmic translocation 
of Cyt c only under the strong apoptotic conditions (Fig. 3 C).
Recent studies demonstrate that Pax3 and Pax7 function 
as survival factors during embryonic and postnatal myogenesis   
(Borycki et al., 1999; Pani et al., 2002; Kassar-Duchossoy et al., 
we  demonstrated  that  after  injection  into  injured  muscle, 
MyoD
/ myoblasts engrafted with significantly higher ef-
ficiency  than  wild-type  myoblasts  (Asakura  et  al.,  2007).   
In addition, MyoD
/ myoblast–derived satellite cells were   
detected underneath the basal lamina of muscle fibers, indicat-
ing that MyoD
/ myoblasts are capable of self-renewal. Impor-
tantly, MyoD
/ myoblasts were revealed to possess remarkable 
resistance to apoptosis with increased survival compared with 
wild-type myoblasts. Therefore, MyoD
/ myoblasts may pre-
serve  stem  cell  characteristics  including  their  resistance  to 
apoptosis, efficiency of engraftment, and improvement in satel-
lite cell contribution after transplantation. However, it remained 
unclear how MyoD actively regulates the apoptotic cascade in 
myoblasts. In this study, we demonstrate that MyoD not only 
regulates  terminal  differentiation  but  also  apoptosis  through   
microRNA (miRNA)-mediated down-regulation of Pax3.
Results
MyoD
/ myoblasts are resistant to 
apoptosis during muscle regeneration
Previously, we reported that MyoD
/ myoblasts display greater 
resistance to apoptosis under differentiation conditions and a 
significantly higher engraftment rate after intramuscular trans-
plantation compared with wild-type myoblasts (Asakura et al., 
2007). Therefore, we first examined the extent of apoptosis in 
skeletal muscle after cardiotoxin (CTX) injection, which in-
duces muscle damage with successive muscle regeneration.   
Together, immunostaining for Pax7, a marker for satellite cells 
and myogenic precursor cells, and TUNEL staining clearly in-
dicated  that  wild-type  tibialis  anterior  (TA)  muscle  displays 
more apoptotic satellite cells and myogenic precursor cells than 
MyoD
/ muscle 2 d after CTX injection (Fig. 1, A and B). 
Next, we compared apoptosis levels after myoblast injection 
into regenerating TA muscle. Myoblasts were prepared from 
skeletal muscle of the control Rosa26 and MyoD
/:Rosa26 
adult mice. 2 d after cell injection into regenerating TA muscle, 
double immunostaining for Pax7 and activated caspase-3 clearly 
indicated that more lacZ
+ Rosa26 myoblasts and their progenies 
underwent apoptosis compared with MyoD
/:Rosa26 cells 
(Fig. 1, C and D).
MyoD is an activator for caspase-3  
and apoptosis
Next, we examined whether MyoD-induced apoptosis was the   
result of caspase-3 activation. Caspase-3 activity and TUNEL 
staining clearly indicated that wild-type myoblasts showed higher 
caspase-3 activity and underwent more apoptosis in differentia-
tion conditions compared with MyoD
/ myoblasts (Figs. 2 A  
and S2 A). In addition, UV exposure, a DNA damage inducer   
(Sabourin et al., 1999), and treatment with thapsigargin, an ER 
stress inducer (Morishima et al., 2004), led to higher caspase-3 ac-
tivity in wild-type myoblasts compared with MyoD
/ myoblasts 
(Figs.  2 A  and  S2 A).  Collectively,  these  data  confirmed  that 
MyoD
/ myoblasts display low caspase-3 activity and are resis-
tant to apoptosis under both in vivo and in vitro conditions versus 
typical apoptotic characteristics observed in wild-type myoblasts.349 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
Figure 1.  MyoD
/ myogenic precursor cells are resistant to apoptosis in vivo. (A) Before CTX injection (day 0), no Pax7
+ TUNEL
+ apoptotic satellite cells 
were detected in wild-type and MyoD
/ TA muscles. 2 d after CTX injection, Pax7
+ TUNEL
+ apoptotic myogenic precursor cells (arrows) were detected 
in wild-type muscles. Bar, 20 µm. (B) Number of Pax7
+ TUNEL
+ apoptotic myogenic precursor cells was quantified. (C) 1 d after CTX injection, myoblasts 
prepared from Rosa26 or MyoD
/:Rosa26 mice were intramuscularly injected into regenerating TA muscle. By 2 d after cell injection, lacZ
+ Pax7
+  
donor-derived myogenic precursor cells were examined for activated caspase-3 expression (arrows). Arrowheads denote lacZ
 Pax7
+ activated caspase-3
+ 
endogenous myogenic precursor cells. Bar, 10 µm. (D) The number of lacZ
+ Pax7
+ activated caspase-3
+ apoptotic myogenic precursor cells was measured. 
Nuclei were counterstained with DAPI (blue). *, P < 0.05; **, P < 0.01. Error bars indicate SEM.JCB • VOLUME 191 • NUMBER 2 • 2010   350
Figure 2.  Expression of MyoD induces apoptosis. (A) Caspase-3 activity was compared between wild-type (wt) and MyoD
/ myoblasts under differ-
entiation conditions from day 0 to 5 or UV exposure or treatment with thapsigargin from 0 to 24 h. (B) Under differentiation conditions from day 0 to 5,   
caspase-3 activity was compared between MyoD
/ myoblasts infected with a lentivirus vector expressing ectopic MyoD and a control empty vector.   
(C) After UV exposure or treatment with thapsigargin (Thap) for 1 d, caspase-3 activity was compared between MyoD
/ myoblasts infected with a   
lentivirus vector expressing ectopic MyoD and a control empty vector. (D and E) Under differentiation conditions from day 0 to 5 or after UV exposure or 
treatment with thapsigargin (Thap) for 1 d, cell death (D) and caspase-3 activity (E) were compared between wild-type myoblasts infected with a lentiviral 
vector expressing shRNA for MyoD and a control shRNA vector. *, P < 0.05; **, P < 0.01. Error bars indicate SEM.351 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
down-regulated Pax3, Bcl-2, and Bcl-xL gene and protein ex-
pression (Fig. 5, A–C). In contrast, MyoD KD in wild-type 
myoblasts increased gene expression of Bcl-2 and Pax3 (Fig. 5 A) 
along with protein expression of Pax3, Bcl-2, and Bcl-xL (Fig. 5, 
B and C). However, altered MyoD expression level did not 
change Pax7 gene expression (Fig. 5 A). These results suggest 
that MyoD negatively regulates Bcl-2, Bcl-xL, and Pax3, which 
activate the apoptotic cascade.
A previous study demonstrated that Pax3 acts as a tran-
scription factor for Bcl-xL gene expression by binding to the 
regulatory region of the Bcl-xL gene (Margue et al., 2000). 
Therefore, up-regulation of Pax3 in MyoD
/ myoblasts may 
2005; Relaix et al., 2006). Therefore, we compared their expres-
sion levels between wild-type and MyoD
/ myoblasts. Inter-
estingly, Pax3 gene and protein expression were highly up- 
regulated  in  MyoD
/  myoblasts  (8.3-fold  in  protein  level) 
compared with wild-type myoblasts, in which Pax3 expression 
levels were very low or nondetectable, as reported previously 
(Fig. 4, A–D; Montarras et al., 2005). In contrast, Pax7 gene and 
protein expression were not altered between the two cell types 
(Fig. 4, A and B). Similar up-regulation of Pax3 protein (4.7-fold) 
was also detected in isolated hind limb muscle from MyoD
/ 
mice compared with wild-type mice (Fig. S4, A and B). Impor-
tantly, the ectopic expression of MyoD in MyoD
/ myoblasts 
Figure  3.  MyoD
/  myoblasts  up-regulate 
antiapoptotic proteins Bcl-2 and Bcl-xL and in-
duce Cyt c release. (A) Expression of antiapop-
totic proteins Bcl-2 and Bcl-xL and proapoptotic 
protein Bak in wild-type and MyoD
/ myo-
blasts was assessed by Western blotting under 
growth conditions (control [Cont]) or after UV 
exposure or treatment with thapsigargin (Thap) 
for 1 d. Mitochondrial (Mito) and cytoplasmic 
(Cyto) protein extracts were also probed with 
antibodies against COX4, Cyt c, or -actin.   
(B)  Cyt  c  translocation  into  cytoplasm  in 
MyoD
/ myoblasts was assessed by Western 
blotting after infection with a lentivirus vector 
expressing  MyoD  or  a  control  empty  vector 
under growth conditions, differentiation condi-
tions (Diff) for 3 d, or after UV exposure or 
treatment with thapsigargin for 1 d. (C) Cyt c 
translocation into cytoplasm in wild-type myo-
blasts was assessed by Western blotting after 
infection  with  a  lentivirus  vector  expressing 
shRNA for MyoD or a control shRNA vector 
under growth conditions, differentiation condi-
tions for 3 d, or after UV exposure or treatment 
with thapsigargin for 1 d. -Actin was moni-
tored as a loading control.JCB • VOLUME 191 • NUMBER 2 • 2010   352
protein expression of Bcl-2 (5.5-fold for protein) and Bcl-xL   
(4.4-fold for protein; Fig. 6, A, B, and D).
To test whether Pax3 functioned as a transcriptional regu-
lator for Bcl-2 and Bcl-xL genes, we performed luciferase (Luc) 
assays using the Bcl-2 and Bcl-xL promoters driving Luc reporter 
genes (Fig. 6 E). Activation of both Bcl-2– and Bcl-xL–Luc   
cause transcriptional up-regulation of Bcl-2 and Bcl-xL and, 
thus, myoblast resistance to apoptosis. Supporting this hypothe-
sis, ectopic expression of Pax3 in wild-type myoblasts increased 
gene and protein expression of Bcl-2 (8.7-fold for protein) and 
Bcl-xL (4.0-fold for protein; Fig. 6, A–C). In contrast, Pax3 
KD by siRNA in MyoD
/ myoblasts down-regulated gene and 
Figure 4.  MyoD
/ myoblasts up-regulate Pax3 expression. (A) Under growth conditions (control [Cont]), differentiation conditions (Diff), UV exposure, or 
treatment with thapsigargin (Thap), Pax3, Pax7, Bcl-2, and Bcl-xL gene expression were compared between wild-type and MyoD
/ myoblasts by RT-PCR.   
(B) Pax3 and Pax7 expression were compared between wild-type and MyoD
/ myoblasts by immunostaining (green). Nuclei were counterstained with 
DAPI (blue). Bar, 40 µm. (C) Pax3 protein expression was compared between wild-type (wt) and MyoD
/ myoblasts by Western blotting. (D) Relative 
Pax3 expression levels normalized by -actin expression shown in C were measured. (A and C) -Actin was monitored as a loading control. **, P < 0.01. 
Error bars indicate SEM.353 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
Therefore, we concluded that MyoD negatively regulates Pax3 
expression in myoblasts by transcriptional and/or posttranscrip-
tional regulation.
MyoD suppresses Pax3 through activation 
of miRNA, miR-1, and miR-206
Recent  work  demonstrates  that  MyoD  directly  regulates  the 
transcription of miRNA expression, which suppresses specific 
targets during myogenic differentiation by blocking protein 
translation and/or by RNA degradation (Chen et al., 2006). We 
identified two potential miR-1– and miR-206–binding sites within 
the 3 untranslated region (UTR) of Pax3 mRNA (Fig. 7 A). 
Both miR-1 and miR-206 are known MyoD-targeting miRNAs 
(Rao et al., 2006). We termed these two potential miR-1– and 
miR-206–binding sites M1 and M2, respectively. Both core   
sequences  are  highly  conserved  among  vertebrates,  suggesting   
reporter genes was higher in MyoD
/ myoblasts compared 
with wild-type myoblasts (1.8-fold and 1.7-fold, respectively).   
Ectopic expression of Pax3 activated both Bcl-2– and Bcl-xL–Luc 
reporter genes in wild-type myoblasts (4.0-fold and 2.3-fold, 
respectively), strongly suggesting that Pax3 is a transcriptional 
activator for Bcl-2 and Bcl-xL genes. Consequently, ectopic 
expression of Pax3 displayed decreased cell death under the 
differentiation conditions (2.0-fold at day 2) and after UV   
exposure (2.5-fold) and treatment with thapsigargin (1.8-fold;   
Fig. 6 F). Finally, after UV exposure, ectopic expression of Pax3 
reduced caspase-3 activity in wild-type myoblasts (3.1-fold), 
whereas  Pax3  KD  increased  caspase-3  activity  in  MyoD
/ 
myoblasts (2.3-fold; Fig. 6 G), indicating the antiapoptotic 
role for Pax3. Collectively, these results indicate that MyoD   
deficiency increases Pax3, enhancing Bcl-2 and Bcl-xL gene ex-
pression to provide resistance to apoptosis in MyoD
/ myoblasts. 
Figure 5.  MyoD negatively regulates Pax3, Bcl-2, and Bcl-xL expression. (A) MyoD, Bcl-2, Bcl-xL, Pax3, and Pax7 gene expression were compared   
between wild-type myoblasts infected with a lentivirus vector expressing shRNA vector for MyoD and a control shRNA vector (Cont) or MyoD
/ myoblasts 
infected with a lentivirus vector expressing MyoD (Ect-MyoD) and a control empty vector by RT-PCR. (B) Bcl-2, Bcl-xL, and Pax3 protein expression were 
compared between wild-type myoblasts infected with a lentivirus vector expressing shRNA vector for MyoD and a control shRNA vector or MyoD
/ myo-
blasts infected with a lentivirus vector expressing MyoD and a control empty vector by Western blotting. (A and B) -Actin was monitored as a loading 
control. (C) Relative Pax3, Bcl-2, and Bcl-xL protein expression levels normalized by -actin expression were measured by Western blotting. *, P < 0.05; 
**, P < 0.01. Error bars indicate SEM.JCB • VOLUME 191 • NUMBER 2 • 2010   354
Figure 6.  Pax3 positively regulates Bcl-2 and Bcl-xL expression. (A) Pax3, Bcl-2, and Bcl-xL gene expression were compared between wild-type myo-
blasts infected with a retrovirus vector expressing Pax3 (Ect-Pax3) and a control empty vector or MyoD
/ myoblasts transfected with siRNA for Pax3 and 
a control siRNA (Cont) by RT-PCR. (B) Pax3, Bcl-2, and Bcl-xL protein expression were compared between wild-type myoblasts infected with a retrovirus 
vector expressing Pax3 and a control empty vector or MyoD
/ myoblasts transfected with siRNA for Pax3 and a control siRNA by Western blotting.   
(A and B) -Actin was monitored as a loading control. (C and D) Relative Pax3, Bcl-2, and Bcl-xL protein expression levels shown in B normalized by -actin 
expression were compared by Western blotting. (E) Luc activity was assessed after transfection with Bcl-2– or Bcl-xL–Luc reporter genes into wild-type or 
MyoD
/ myoblasts. Luc activity was also assessed after transfection with Bcl-2– or Bcl-xL–Luc reporter genes and the Pax3 expression vector or control empty 
vector into wild-type myoblasts. (F) Under differentiation conditions from day 0 to 3 or after UV exposure or treatment with thapsigargin (Thap) for 1 d, cell 
death was compared between wild-type myoblasts infected with a retrovirus vector expressing Pax3 and a control empty vector. (G) After UV exposure or 
treatment with thapsigargin for 1 d, caspase-3 activity was compared between wild-type and MyoD
/ myoblasts infected with a retrovirus vector expressing 
Pax3 and a control empty vector or transfected with siRNA for Pax3 and a control siRNA. *, P < 0.05; **, P < 0.01. Error bars indicate SEM.355 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
the mutant reporter gene (CMV-Luc-3UTRM) for both wild-
type and MyoD
/ myoblasts (Fig. 8 B). Similarly, transfection 
of pre–miR-1 and pre–miR-206 also suppressed Luc activity 
in CMV-Luc-3UTR in both wild-type (2.4-fold and 1.9-fold, 
respectively) and MyoD
/ myoblasts (2.8-fold and 2.0-fold, 
respectively) but did not suppress Luc activity in CMV-Luc-
3UTRM (Fig. 8 C). These results suggest the direct binding 
of miR-1/miR-206 to the M1 and/or M2 sites within the longer 
3UTR of Pax3. Importantly, transfection with pre–miR-1 and 
pre–miR-206 increased cell death in MyoD
/ myoblasts under 
differentiation conditions (3.0-fold and 3.1-fold at day 2 dif-
ferentiation, respectively) and after UV exposure (2.7-fold and 
2.8-fold, respectively) and treatment with thapsigargin (5.3-fold 
and 5.2-fold, respectively; Fig. 8 D). In addition, transfection   
of pre–miR-1 and pre–miR-206 increased MHC-positive myo-
genic differentiation of wild-type myoblasts, whereas over-
expression of Pax3 partially suppressed myogenic differentiation   
(Fig. S4, C–E). Finally, transfection with antagomirs for miR-1 
and miR-206 partially suppressed apoptosis after UV exposure 
and treatment with thapsigargin in both wild-type myoblasts 
and MyoD
/ myoblasts expressing ectopic MyoD (Fig. 8 E). 
These results strongly suggest that MyoD regulates the tran-
scription of miR-1/miR-206 expression, which in turn directly 
suppresses Pax3 expression in myoblasts. Down-regulation of 
Pax3 results in down-regulation of Bcl-2 and Bcl-xL to induce 
apoptosis under stressful conditions.
To examine whether 3UTR of Pax3 was important for 
the expression level of Pax3, we created retrovirus Pax3 expres-
sion vectors: one containing 3UTR (Pax3-3UTR) and another 
3UTR with mutations at M1 and M2 (Pax3-3UTRM). Com-
pared  with  Pax3  expression  vector,  Pax3-3UTR  expression 
vector  showed  significantly  reduced  Pax3  expression  levels 
(2.6-fold) detected by immunostaining and RT-PCR (Fig. 9, A–C).   
This reduction was attenuated by mutations at M1 and M2 in the 
3UTR (Pax3-3UTRM), confirming that Pax3-3UTR is a target 
for  miRNAs.  These  Pax3  expression  levels  affected  caspase-3   
activity in the myoblasts after treatment with thapsigargin. 
Although  expression  of  Pax3  or  Pax3-3UTRM  inhibited   
caspase-3 activity in wild-type myoblasts, this inhibition was 
reduced by Pax3-3UTR expression (Fig. 9 D), suggesting that 
Pax3 expression levels regulated by the 3UTR affect apoptosis 
in myoblasts.
Recently, dicer gene has been shown to process miRNA 
precursors into functional 21–23 nucleotide RNAs (Wang and 
Olson, 2009). Dicer gene knockout mice display early embryonic 
lethality with a variety of developmental phenotypes because   
of significant reduction in maturation of miRNAs (Harfe et al., 
2005). We isolated satellite cell–derived myoblasts from floxed 
dicer adult mice (dicer
fl/fl). An adenovirus vector expressing a 
fusion gene of Cre recombinase and EGFP was infected to the 
dicer
fl/fl myoblasts. 2 d after infection, most of the cells became 
EGFP
+ and deleted dicer gene (Fig. 9, E and F). These myoblasts 
with deleted dicer gene display growth retardation and reduc-
tion of expression for several miRNAs and muscle-specific 
genes (Fig. 9 G). In contrast, expression of Pax3 was up-regulated 
in the myoblasts with deleted dicer gene, confirming that Pax3 
gene expression is regulated by miRNAs.
the  importance  of  these  sites  for  Pax3  regulation  (Fig.  7,   
A and B). For mouse Pax3, there are two putative polyA sig-
nal sequences in the 3UTR. Both proximal (polyA1) and distal 
(polyA2) polyA signal sequences were indeed used for tran-
scription of Pax3 mRNAs with the shorter and longer 3UTRs,   
respectively (Fig. 7 A). The longer 3UTR contains both putative 
miR-1– and miR-206–binding sites. In contrast, the human Pax3 
gene only contains polyA2 sequence, and thus, the human Pax3 
mRNA contains the longer 3UTR with the two putative miR-1/
miR-206–binding sites (Barber et al., 1999). In both human and 
mouse Pax3 genes, there are several alternative splicing variants 
using multiple stop codons (Fig. 7 A). Semiquantitative RT-
PCR data clearly showed that the longer 3UTR was used for 
Pax3 expression in MyoD
/ myoblasts (Fig. 7 C), suggesting 
that miR-1/miR-206 may negatively regulate Pax3 expression 
through binding to M1 and/or M2 sites.
MyoD regulates transcription of several target miRNAs, 
including miR-1, miR-22, miR-100, miR-133a, miR-191, and 
miR-206 (Chen et al., 2006; Kim et al., 2006; Rao et al., 2006; 
Rosenberg et al., 2006). Among them, only miR-1 and miR-206 
were markedly down-regulated in MyoD
/ myoblasts. Expres-
sion of miR-133a was also slightly down-regulated in MyoD
/ 
myoblasts. These data indicate that miR-1, miR-206, and miR-
133a are direct downstream target genes of MyoD in primary 
myoblasts (Fig. 7 D). Recent work showed that miR-27b binds 
to the shorter 3UTR to suppress Pax3 expression during em-
bryonic myogenesis and satellite cell activation (Crist et al., 2009). 
However, expression of miR-27b was very low in both wild-
type and MyoD
/ myoblasts. Therefore, MyoD-mediated Pax3 
down-regulation is most likely to be mediated by miR-1 and   
miR-206 in primary myoblasts. Indeed, miR-1 and miR-206 were 
up-regulated in wild-type and MyoD
/ myoblasts by ectopic ex-
pression of MyoD (Fig. 7 E). In contrast, MyoD KD decreased 
both miRNAs in wild-type myoblasts. Expression of miR-1 or 
miR-206 indeed suppressed Pax3, Bcl-2, and Bcl-xL gene ex-
pression without affecting Pax7 gene expression (Fig. 7 F).
Next,  we  examined  whether  transfection  of  wild-type 
myoblasts with anti-miRNAs (antagomirs) directed against miR-1 
and miR-206 promoted the expression of Pax3, Bcl-2, and Bcl-xL 
(Fig. 7 G). Clearly, transfection with antagomirs for miR-1 and 
miR-206 increased expression levels of Pax3, Bcl-2, and Bcl-xL 
compared with the control. The combination of antagomirs for 
miR-1 and miR-206 more efficiently up-regulated expression of 
Pax3, Bcl-2, and Bcl-xL without affecting Pax7 gene expression. 
It has been reported that Bcl-2 gene expression is suppressed by 
miR-15a and miR-16 (Cimmino et al., 2005). However, altera-
tion of MyoD expression in wild-type or MyoD
/ myoblasts 
did not affect expression of these two miRNAs (Fig. S3 B), indi-
cating that MyoD does not negatively regulate the transcription 
of Bcl-2 by means of these miRNAs.
To elucidate whether miR-1 and miR-206 directly bound 
to the 3UTR of Pax3, we created Luc reporter genes conju-
gated with the longer Pax3-3UTR (cytomegalovirus [CMV]-
Luc-3UTR) and the longer Pax3-3UTR with mutations at M1 
and M2 (CMV-Luc-3UTRM; Fig. 8 A). As a result, MyoD 
transfection suppressed Luc activity in the wild-type reporter 
gene (CMV-Luc-3UTR) but did not suppress Luc activity in JCB • VOLUME 191 • NUMBER 2 • 2010   356
Figure 7.  Pax3-3UTR contains conserved miR-1/miR-206–binding sites. (A) Mouse Pax3 gene structure. Numbered boxes denote each exon. White 
boxes denote the 5UTR and the shorter 3UTR. Black boxes denote coding regions. The gray box denotes the longer 3UTR containing two putative 
miR-1/miR-206–binding sites (M1 and M2). There are two stop codons and two polyA signal sequences (polyA1 and polyA2) in the mouse Pax3 gene.   
(B) Sequences of two putative miR-1/miR-206–binding sites (M1 and M2) and their flanking regions. Core sequences for miR-1/miR-206 and consensus 
sequences are denoted by bold letters. (C) Similar levels of expression of the Pax3 coding region and the longer 3UTR were detected in MyoD
/ myo-
blasts by RT-PCR. -Actin was monitored as a loading control. (D) MyoD-regulated miRNA expression levels were compared between wild-type (wt) and 
MyoD
/ myoblasts by RT-PCR. miR-24 was monitored as a loading control. (E) miR-1 and -206 expression were compared between wild-type myoblasts 
infected with a lentivirus vector expressing shRNA for MyoD and control shRNA (Cont) vector or MyoD
/ myoblasts infected with a lentivirus vector 
expressing MyoD (Ect-MyoD) and a control empty vector by RT-PCR. miR-24 was monitored as a loading control. (F) Pax3, Pax7, Bcl-2, and Bcl-xL gene 
expression were compared between MyoD
/ myoblasts transfected with pre–miR-1, pre–miR-206, and the control pre-miRNA by RT-PCR. -Actin was 
monitored as a loading control. (G) Pax3, Pax7, Bcl-2, and Bcl-xL gene expression were compared between wild-type myoblasts transfected with anti–miR-1 
(anti-1), anti–miR-206 (anti-206), anti–miR-1 + anti–miR-206 (anti-1 + 206), and the control RNA by RT-PCR. -Actin was monitored as a loading control.   
(D and E) All PCR products are 90-bp long.357 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
Figure 8.  Pax3-3UTR is a target for miR-1 and miR-206. (A) CMV promoter driving Luc reporter gene was used for creating Luc-3UTR, which contains the 
longer Pax3-3UTR fragment downstream of the Luc reporter gene. Two putative miR-1/miR-206–binding sites (M1 and M2) were mutated in Luc-3UTRM. 
(B) Relative Luc activity was measured in wild-type and MyoD
/ myoblasts after transfection with control Luc reporter gene + empty expression vector,   
Luc-3UTR + empty expression vector, Luc-3UTR + MyoD expression vector, and Luc-3UTRM + MyoD expression vector. (C) Relative Luc activity was measured 
in wild-type and MyoD
/ myoblasts after transfection with Luc-3UTR + control pre-miRNA, Luc-3UTR + pre–miR-1, Luc-3UTR + pre–miR-206, Luc-3UTRM + 
control pre-miRNA, Luc-3UTRM + pre–miR-1, and Luc-3UTRM + pre–miR-206. (D) Under differentiation conditions from day 0 to 3 or after UV exposure   
or treatment with thapsigargin (Thap) for 1 d, cell death was compared between wild-type myoblasts transfected with the control pre-miRNA, pre–miR-1, 
and pre–miR-206. (E) After UV exposure or treatment with thapsigargin for 1 d, cell death was compared between wild-type myoblasts or MyoD
/ myo-
blasts expressing ectopic MyoD transfected with the control miRNA or anti–miR-1 + anti–miR-206. *, P < 0.05; **, P < 0.01. Error bars indicate SEM.JCB • VOLUME 191 • NUMBER 2 • 2010   358
Figure 9.  Pax3 expression is regulated by dicer and Pax3-3UTR. (A) Pax3 expression was compared between wild-type myoblasts infected with a 
retrovirus vector expressing Pax3, Pax3-3UTR, Pax3-3UTR with mutations at miR-1/miR-206–binding sites (Pax3-3UTRM), and a control empty vector 
by immunostaining (green). Nuclei were counterstained with DAPI (blue). (B) Pax3, Pax7, Bcl-2, and Bcl-xL gene expression were compared between 
wild-type myoblasts transfected with Pax3, Pax3-3UTR, Pax3-3UTRM, and a control empty vector by RT-PCR. (C) Relative Pax3 expression levels shown 
in B normalized by -actin expression were measured. (D) After treatment with thapsigargin for 1 d, caspase-3 activity was compared between wild-type 
myoblasts infected with a retrovirus vector expressing Pax3, Pax3-3UTR and Pax3-3UTRM, and a control empty vector. (E) Myoblasts isolated from floxed 
dicer (dicer
fl/fl) mice were infected with adenovirus lacZ expression vector (control [Cont]) or adenovirus Cre/EGFP expression vector. GFP is only detected 
in myoblasts infected with adenovirus Cre/EGFP expression vector. (F) Control myoblasts infected with adenovirus lacZ expression vector shows the loxP 
band but not excised band after PCR. Infection with more adenovirus Cre/EGFP expression vector (10 and 100 µl) increased in amount of the excised band 359 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
(33.3% of cells) but still significantly higher than in wild-type 
ASCs (11.7% of cells). The ectopic expression of MyoD in 
MyoD
/ satellite cells down-regulated Pax3 gene expression. 
In contrast, MyoD KD in wild-type myoblasts increased gene 
expression of Pax3 (Fig. 10, C and D). Therefore, these results 
suggest that part of down-regulation of Pax3 may be mediated 
by MyoD-induced miR-1 and miR-206 during wild-type satel-
lite cell activation. Collectively, these results suggest that MyoD 
can induce apoptosis through activation of miR-1 and miR-206 
that decrease the level of the antiapoptotic protein Pax3, which 
in turn decreases Bcl-2 and Bcl-xL (Fig. 10 E).
Discussion
MyoD is a master transcription factor for myogenic specifica-
tion and terminal differentiation (Weintraub et al., 1991). In this 
study, we demonstrate that MyoD not only regulates myogenic 
terminal differentiation but also acts as a proapoptotic factor. 
We have identified molecules downstream of MyoD that regu-
late apoptosis in myoblasts; negative regulation of Pax3 expres-
sion occurs through direct transcriptional activation of miR-1 
and miR-206 gene expression. Pax3 is a survival factor that tran-
scriptionally activates the antiapoptotic genes Bcl-2 and Bcl-xL. 
Therefore, negative regulation of Pax3 expression by MyoD-
regulated miRNAs is a critical point for MyoD-dependent apopto-
sis in myoblasts.
One interesting notion is that skeletal muscle fibers and 
placental  villous  trophoblast  are  the  main  representatives  of 
syncytia, which are derived from the fusion of mononucleated 
stem cells. The molecules regulating the apoptosis cascade, 
such as caspase-3 and caspase-8, are also involved in differenti-
ation and syncytial fusion in both tissues (Huppertz et al., 2001; 
Fernando et al., 2002). Several studies have suggested that myo-
genic differentiation is accompanied by apoptosis (Sandri and 
Carraro, 1999). For example, proliferating C2C12 myoblasts 
can undergo either terminal differentiation or apoptosis under 
conditions of mitogen deprivation (Wang and Walsh, 1996). 
Previous work suggested a proapoptotic role for MyoD, show-
ing that MyoD can promote apoptotic cell death in myoblasts 
when pRb function is lacking (Fimia et al., 1998; Peschiaroli et al., 
2002). Recently, we and other groups have reported that MyoD 
deficiency led to the down-regulation of many antiapoptotic 
genes such as Bcl-2 (Asakura et al., 2007) and proapoptotic 
genes such as PUMA (Harford et al., 2010). Bcl-2 expression in 
myoblasts  inhibits  apoptosis  and  promotes  clonal  expansion 
(Dominov et al., 2005). Indeed, satellite cells from young rats 
had increased numbers of Bcl-2–positive cells (Jejurikar et al., 
2006). In contrast, the proapoptotic factor Bax is increased in 
satellite cells of old rat muscle (Krajnak et al., 2006). Therefore, 
in old muscle, apoptosis may play a causative role in the depletion 
of satellite cells, impairing the regenerative response to injury. 
We have shown that expression of both Pax3 RNA and 
protein is considerably enhanced in MyoD-deficient myoblasts. 
It is not clear whether the augmentation of Pax3 RNA levels in 
these cells was caused by increased transcription or increased 
stability of the mRNA. Therefore, to examine whether there 
was differential transcription of the Pax3 gene in wild-type   
versus MyoD
/ myoblasts, a chromatin immunoprecipitation 
(IP [ChIP]) assay with antibodies against RNA polymerase II was 
performed (Fig. 9 H). Clearly, transcription of the Pax3 gene 
was still active in wild-type myoblasts, whereas it was relatively 
more active in MyoD
/ myoblasts. Therefore, Pax3 RNA level 
in wild-type myoblasts is regulated by transcriptional level and 
stability of the mRNA through miRNAs.
Recent work demonstrates that freshly isolated quiescent 
satellite cells (QSCs) display unique gene expression profiles 
(Fukada et al., 2007). In particular, QSCs do not express MyoD 
but, after isolation, become activated to activated satellite cells 
(ASCs) and up-regulate MyoD within 1 d (Cornelison et al., 
2000; Zammit et al., 2002). In addition, some QSCs isolated 
from mouse hind limb down-regulate Pax3 gene and protein 
expression when they become ASCs (Montarras et al., 2005; 
Boutet et al., 2007; Crist et al., 2009). We isolated QSCs by 
FACS  as  CD45
  CD31
  Sca-1
  integrin-7
+  integrin-1
+ 
fraction from hind limb muscles of wild-type and MyoD
/ 
mice. The percentages of integrin-7 and -1 double-positive 
QSCs per total events were slightly higher in MyoD
/ muscle   
(0.78 ± 0.01; n = 3) compared with wild-type muscle (0.70 ± 
0.02; n = 3; Fig. S5 A), which is consistent with previously re-
ported results (Megeney et al., 1996).
After sorting, QSCs were cultured to obtain ASCs. Semi-
quantitative RT-PCR confirmed that MyoD was absent in QSCs 
but present in wild-type ASCs at day 1 (Fig. 10 A). miR-1 and 
miR-206 were gradually up-regulated in wild-type ASCs with 
the highest levels at day 4, suggesting potential roles for miR-1   
and miR-206 in satellite cell activation. Neither miR-1 nor 
miR-206 was detected in MyoD
/ QSCs or ASCs. Pax3, Bcl-2,   
and Bcl-xL were initially expressed in wild-type QSCs but 
quickly down-regulated in wild-type ASCs (Fig. 10, A and B). 
In MyoD
/ cells, Pax3, Bcl-2, and Bcl-xL expression were   
also high in QSCs but down-regulated in ASCs at days 1   
and 2. In contrast to wild-type myoblasts, Pax3, Bcl-2, and   
Bcl-xL expression were retained in MyoD
/ ASCs at day 4 
(Fig. 10, A and B).
Immunostaining clearly showed that most of the freshly 
isolated QSCs from both wild-type and MyoD
/ mice were 
positive for c-met, a marker for satellite cells (Fig. S5, B and C).   
Pax3-positive MyoD
/ QSCs (70.1%) were significantly higher 
than wild-type QSCs (30.1%). After culture, Pax3 expression 
was quickly down-regulated in Pax7-positive wild-type ASCs, 
as previously reported (Montarras et al., 2005; Boutet et al., 
2007). In MyoD
/ ASCs, Pax3 was also down-regulated at day 1   
(Cre10 and Cre 100, respectively). (G) Cre, dicer, myogenic marker, and miRNA expression were compared between control dicer
fl/fl myoblasts infected 
with adenovirus lacZ expression vector and infected with adenovirus Cre/EGFP expression vector by RT-PCR. For miRNAs, all PCR products are 90-bp 
long. (H) ChIP assay with antibody against RNA polymerase II was performed. Input denotes each PCR product from naked myoblast genomic DNA. Pax3 
and Pax7 but not Ig heavy chain (IgH) were detected by ChIP assay in wild-type (wt) and MyoD
/ myoblasts. (B and G) -Actin was monitored as a load-
ing control. *, P < 0.05; **, P < 0.01. Error bars indicate SEM. Bars, 20 µm.
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Figure 10.  Pax3 expression is down-regulated during satellite cell activation. (A) MyoD, Pax3, Pax7, Bcl-2, Bcl-xL, miR-1, and miR-206 gene expression were 
compared between freshly isolated (day 0) and cultured satellite cells (days 1, 2, and 4) derived from wild-type and MyoD
/ mice by RT-PCR. 18S rRNA and 
miR-24 were monitored as loading controls. For miRNAs, all PCR products are 90-bp long. (B) Relative Pax3, Bcl-2, and Bcl-xL gene expression levels shown 
in A normalized by 18S rRNA expression were measured. (C) MyoD and Pax3 gene expression were compared between wild-type satellite cells transfected 
with siRNA for MyoD and a control siRNA (Cont) or MyoD
/ satellite cells infected with a lentivirus vector expressing MyoD (Ect-MyoD) and a control empty 
vector by RT-PCR. (D) Relative Pax3 gene expression shown in C normalized by 18S rRNA expression was measured. (E) The model for apoptotic cascade 
regulated by MyoD. MyoD is a master regulator for muscle differentiation. Under differentiation or stressful conditions, MyoD transcriptionally activates miR-1   
and miR-206 gene expression, which suppresses Pax3 expression. Down-regulation of Pax3 results in down-regulation of Bcl-2 and Bcl-xL, which causes 
apoptosis. In addition, down-regulation of Pax3 by MyoD also induces muscle differentiation. *, P < 0.05; **, P < 0.01. Error bars indicate SEM.361 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
c-met expression in rhabdomyosarcomas (Taulli et al., 2009). 
Expression of miR-1 or miR-206 in these tumors promotes 
myogenic differentiation and blocks tumor growth, potentially 
through inhibition of Pax3 expression. Reduced muscle miRNAs 
in muscle-specific dicer gene knockout mice results in peri-
natal death and decreased skeletal muscle mass accompanied 
by abnormal myofiber morphology, indicating the essential role 
for dicer gene in normal muscle development during embryo-
genesis (O’Rourke et al., 2007). We showed that dicer gene 
knockout myoblasts up-regulated Pax3 gene expression, indi-
cating that the Pax3 gene is regulated by miRNAs. In addition, 
several muscle specific genes are down-regulated in the dicer 
gene knockout myoblasts, suggesting that dicer gene knockout 
may change broader gene expression in myoblasts, causing the 
muscle phenotypes seen in the dicer gene knockout mice.
Recent work demonstrates that freshly isolated satellite 
cells but not cultured satellite cells contribute remarkably to 
muscle fiber regeneration after intramuscular transplantation 
(Collins et al., 2005; Montarras et al., 2005; Cerletti et al., 2008; 
Sacco et al., 2008; Tanaka et al., 2009). Freshly isolated satellite 
cells do not express MyoD until activation (Cornelison et al., 
2000). Instead, these cells express Pax3 (Montarras et al., 2005; 
Boutet et al., 2007), Bcl-2, and Bcl-xL (this study), but expres-
sion is quickly down-regulated after activation. Therefore, the 
QSC population may possess more resistance to apoptosis than 
ASCs. The down-regulation of MyoD and up-regulation of 
Pax3 may also be required for maintenance of self-renewing 
satellite cells. For clinical purposes, myogenic progenitor cells 
with either suppressed proapoptotic genes such as MyoD or 
miR-1/miR-206 or with forced expression of Pax3 could be 
screened for their potential to efficiently engraft in damaged 
muscle, effectively contribute to muscle fiber regeneration, and 
systemically improve muscle function in muscular dystrophy 
patients.  In  addition,  these  genetically  engineered  myogenic 
progenitor cells would be beneficial for therapy by providing a 
selective advantage in the expansion of muscle stem cells.
Materials and methods
Animals
MyoD
/ mice (Rudnicki et al., 1992) were provided by M.A. Rudnicki 
(Ottawa Health Research Institute, Ottawa, Ontario, Canada). MyoD
/ 
mice and wild-type mice were used for isolation of MyoD
/ and wild-type 
primary myoblasts. Rosa26 (Zambrowicz et al., 1997) and dicer
fl/fl mice 
(Harfe et al., 2005) were purchased from The Jackson Laboratory. Nod/
Scid-immunodeficient mice were purchase from Charles River. MyoD
/:
Rosa26 mice were established by crossing MyoD
/ mice with Rosa26 
mice. Genotyping to detect the mutated alleles of MyoD
/ and Rosa26 
mice was performed by PCR using primers described by The Jackson Labo-
ratory. Genotyping to detect the floxed dicer alleles of dicer
fl/fl mice was 
performed by PCR using primers (floxed dicer forward and reverse) indi-
cated in Fig. S1. All protocols were approved by the Animal Care and Use 
Committee of the University of Minnesota.
FACS
QSCs were isolated from the hind limb skeletal muscle of 1–2-mo-old mice 
after  muscle  digestion  with  collagenase  type  B  and  dispase  II  (Roche; 
Asakura et al., 2002). FACS was performed on an FACS sorter equipped 
with triple lasers (Aria; BD). The following antibodies were used for FACS 
sorting:  integrin-7  (MBL  International)  with  Alexa  Fluor  488–labeled 
anti–mouse IgG, biotin-labeled integrin-1 with allophycocyanin (APC)-
labeled avidin, phycoerythrin (PE)-labeled CD45, PE-labeled CD31, and 
PE-labeled Sca-1 (all obtained from BD; Kuang et al., 2007). Mouse and 
In this study, we demonstrate that MyoD negatively regulates 
Bcl-2 and Bcl-xL gene expression through down-regulation of 
Pax3 in satellite cell–derived myoblasts. This cascade might 
also  be  involved  in  aging-related  and  pathological  satellite   
cell apoptosis during muscle regeneration. X-linked inhibitor   
of apoptosis protein was reported as an inhibitor for myotube 
apoptosis, which occurs normally in muscle development,   
aging, and neuromuscular diseases (Potts et al., 2005; Smith   
et al., 2009). However, x-linked inhibitor of apoptosis protein 
expression  was  not  significantly  changed  between  wild-type 
and MyoD
/ myoblasts.
Experiments from gene knockout mice demonstrate that 
Pax3 functions as survival factors during embryogenesis (Borycki 
et al., 1999; Pani et al., 2002). It has been reported that Pax3 
positively regulates Bcl-xL gene expression by binding to the   
5 flanking region of the Bcl-xL gene (Margue et al., 2000). Previ-
ously, screening of binding proteins for the 1 kb Bcl-2 promoter 
identified 43 different transcription factors including Pax3 (Li 
et al., 2007). We demonstrate that Pax3 positively regulates 
Bcl-2 gene expression via the 5 flanking region of this gene, 
strongly indicating that Pax3 functions as an antiapoptotic fac-
tor by transcriptionally up-regulating Bcl-2 and Bcl-xL gene 
expression. Pax3 also facilitates the malignant progression of 
rhabdomyosarcomas and melanomas (Blake and Ziman, 2003; 
Robson et al., 2006). Pax3 expression is subject to posttran-
scriptional regulation. Timely down-regulation of Pax3 protein 
is crucial for myogenic differentiation. Recent work demon-
strates that Pax3 expression is regulated by multiple stages, 
including ubiquitination-mediated protein degradation (Boutet 
et al., 2007), Staufen 1–mediated mRNA decay (Gong et al., 
2009),  and  miR-27b–mediated  translational  inhibition  (Crist   
et  al.,  2009).  We  have  demonstrated  that  MyoD  negatively 
regulates Pax3 gene expression through the action of miRNAs.   
Because Pax3 functions as a cell fate determination factor   
and for maintenance of the undifferentiated state in muscle and   
melanocyte  stem  cells,  down-regulation  of  Pax3  is  essential 
for the terminal differentiation, which is also accompanied by 
apoptosis. Overexpression of MyoD or inhibition of Pax3 by 
miRNAs  may  induce  apoptosis  in  rhabdomyosarcomas  and 
melanoma cells, which may provide a novel anticancer therapy   
for associated tumors (Bernasconi et al., 1996; He et al., 2005).
Previous  work  has  demonstrated  that  MyoD  utilizes   
miRNAs,  including  miR-1  and  miR-206,  to  suppress  down-
stream gene expression (Chen et al., 2006; Rosenberg et al., 
2006). We have demonstrated that miR-1 and miR-206 bind to 
two  miR-1/miR-206–binding  sequences  within  Pax3-3UTR 
and suppress Pax3 expression. We showed that Pax3 expres-
sion increases cell survival and suppresses myogenic differen-
tiation in myoblasts. In contrast, miR-1 or miR-206 expression 
increases cell death and myogenic differentiation. Therefore,   
down-regulation of Pax3 is required for proper myogenic dif-
ferentiation, which also results in increased apoptosis. These re-
sults are very similar to Pax7, which is involved in maintaining   
proliferation, preventing precocious differentiation, and protect-
ing against apoptosis (Relaix et al., 2006; Zammit et al., 2006; 
Olguin et al., 2007). Recently, miR-1 and miR-206 have been 
shown to act as potent tumor suppressor genes, which inhibit JCB • VOLUME 191 • NUMBER 2 • 2010   362
rat normal IgG (BD) were used in the control experiment. Alexa Fluor 488 
and PE were excited by a 488-nm argon laser, and their fluorescence 
was detected with an FL1 (530/30) or FL2 (576/26) filter, respectively. 
APC was excited by a 633-nm red diode laser for the detection with an 
FL4 filter (620/20). Sorting gates were strictly defined based on single 
antibody–stained control cells and the forward scatter and side scatter 
patterns of satellite cells. After the forward scatter/side scatter gating, the 
triple-negative cells for CD45-PE, CD31-PE, and Sca-1-PE were gated out. 
Lastly, double-positive cells for integrin-7 Alexa Fluor 488 and integrin-1 
APC were sorted to enrich for QSCs (Kuang et al., 2007). Sorted QSCs 
were immediately characterized by immunostaining on slide glasses or 
cultured on collagen-coated chamber slides (Thermo Fisher Scientific) in the 
myoblast growth medium to obtain ASCs.
Cell cultures
Satellite  cell–derived  myoblasts  were  isolated  from  the  hind  limbs  of   
2-mo-old wild-type BALB/c and MyoD
/ mice by FACS (Hirai et al., 2010). 
The myoblasts were maintained on collagen-coated dishes in myoblast 
growth medium (Asakura et al., 2001) consisting of HAM’s F-10 medium 
supplemented with 20% FBS and 5 ng/ml basic FGF (R&D Systems). Cell 
cultures were maintained in a humidified incubator at 37°C with 5% CO2 
and 5% O2. To induce differentiation of myoblasts, the culture medium was 
replaced with differentiation medium that contained DME supplemented 
with 5% horse serum on day 0. The cells were both harvested from day 0 
(immediately before switching to the differentiation medium) to day 5 for 
Western blotting and also fixed with 2% formaldehyde for immunostaining. 
The medium was changed daily, and cultures were routinely passaged as 
they reached 60–70% confluence. To ensure that the muscle cells retained 
physiological characteristics, all experiments were performed using cells 
that had been passaged between four and eight times.
Intramuscular injection of myoblasts
Muscle regeneration was induced in TA muscle of adult Nod/Scid mice by 
injection of 50 µl 10 µM CTX (Latoxan; Asakura et al., 2002). 1 d later, 
Rosa26- or MyoD
/:Rosa26 myoblasts (10
6 cells) were injected into re-
generating TA muscle. 2 d after injection of cells, TA muscles were harvested 
and stained with x-gal as described previously (Asakura et al., 2002), and 
8-µm frozen sections were prepared for immunohistochemistry.
Immunostaining for muscle sections
After x-gal staining of TA muscle sections, TUNEL staining (Promega) was 
performed following the manufacturer’s instructions. Anti-Pax7 antibody 
(Developmental Biology Hybridoma Bank) followed by Alexa Fluor 488–
conjugated anti–mouse IgG secondary antibody (Invitrogen) was used for 
immunostaining to detect apoptosis in myogenic precursor cells. To detect 
apoptosis in engrafted myogenic precursor cells, lacZ-stained TA muscle   
sections  were  incubated  with  anti-Pax7  antibody  and  anti–activated   
caspase-3  antibody  (Abcam)  followed  by  Alexa  Fluor  488–conjugated 
anti–mouse IgG and Alexa Fluor 594–conjugated anti–rabbit secondary 
antibodies (Invitrogen) for double immunostaining. DAPI (Sigma-Aldrich) 
was used for counterstaining of nuclei. Fluorescence images were cap-
tured using a digital camera (DP-1) attached to an inverted fluorescence 
microscope (CKX31) with 20× and 40× LUCPlanFLN objectives and a 
fluorescence microscope (BX51) with 20× and 40× UPlanFLN objectives 
(all obtained from Olympus). Photoshop (version 7.0; Adobe) was used for 
image processing.
Immunological staining for cell culture
Immunostaining  was  performed  with  an  anti-sarcomeric  MHC  (MF20;   
Developmental  Studies  Hybridoma  Bank),  anti-MyoD  antibody  (Ab-1; 
Thermo Fisher Scientific), anti-Pax3 antibodies (Developmental Studies   
Hybridoma Bank and EMD), anti-Pax7 antibody, and anti–c-met antibody 
(Santa Cruz Biotechnology, Inc.) followed by Alexa Fluor 488–conjugated 
anti–mouse IgG antibody (Invitrogen). For Pax3 staining, the TSA kit (Invitro-
gen) was used for fluorescence signal amplification. Cell cultures were also 
nuclear stained with DAPI.
Gene KD
MyoD siRNA (Santa Cruz Biotechnology, Inc.), Pax3 siRNA (Santa Cruz 
Biotechnology, Inc.), and control siRNA-A (Santa Cruz Biotechnology, Inc.) 
were  transfected  in  wild-type  or  MyoD
/  myoblasts  by  Lipofectamine   
2000 (Invitrogen) following the manufacturer’s instructions. A lentivirus-
  derived shRNA vector for MyoD KD was also created in our laboratory. Short 
hairpin loops for the lentivirus shRNA were designed according to BLOCK-iT 
RNAi  Designer  (Invitrogen),  and  the  vector  plasmids  were  constructed   
using the BLOCK-iT Lentiviral RNAi Expression System (Invitrogen) according 
to  the  manufacturer’s  instructions.  The  following  oligonucleotides  were 
used for lentivirus vectors expressing two different shRNAs for MyoD: (top 
strand) 5-CACCGCTACGACACCGCCTACTACACGAATGTAGTAGGCG-
GTGTCGTAGC-3 and (bottom strand) 5-AAAAGCTACGACACCGCCTA-
CTACATTCGTGTAGTAGGCGGTGTCGTAGC-3 or (top strand) 5-CACC-
GCAAGCGCAAGACCACCAACGCGAACGTTGGTGGTCTTGCGC-
TTGC-3 and (bottom strand) 5-AAAAGCAAGCGCAAGACCACCAAC-
GTTCGCGTTGGTGGTCTTGCGCTTGC-3. The target sequence for MyoD 
shRNA is 5-GCTACGACACCGCCTACTACA-3 and 5-GCAAGCGCAA-
GACCACCAACG-3. The following oligonucleotides were used for a control   
lentivirus vector expressing shRNA for GFP: (top strand) 5-CACCGCTT-
GGGTGGAGAGGCTATTCCGAAGAATAGCCTCTCCACCCAAGC-3 
and (bottom strand) 5-AAAAGCTTGGGTGGAGAGGCTATTCTTCGGAA-
TAGCCTCTCCACCCAAGC-3. The target sequence for control shRNA is   
5-GCTTGGGTGGAGAGGCTATTC-3. Lentivirus vectors expressing shRNA 
for MyoD or GFP as a control were transfected into 293T cell lines, and   
the culture supernatant was used for infection experiments. For MyoD KD, 
culture supernatant derived from cells transfected with two different lenti-
virus vectors were mixed and used for infection into myoblasts at the same 
time. Infection with the lentivirus vectors was performed every day for 3 d. 
1 d after final infection, cells were harvested for gene expression and   
assessed by RT-PCR, immunohistochemistry, and Western blotting or exam-
ined for apoptosis assays.
Plasmid vector construction
A  retrovirus  vector  pMX-Pax3  carrying  the  CMV  promoter  driving  the 
mouse Pax3 gene was used for Pax3 overexpression experiments. Pax3 
cDNA was inserted into the pMXs retrovirus vector (Kitamura et al., 2003). 
Luc reporter genes conjugating with the mouse Pax3-3UTR were created 
from the backbone of pGL3 control vector (Promega), which contains SV40   
enhancer/promoter-driving  Luc  gene.  For  pLuc-3UTR  and  pMX-Pax3-
3UTR, the Pax3-3UTR fragment (1,225 bp) was amplified by RT-PCR using   
Platinum Pfx polymerase (Invitrogen), Pax3-E3 forward primer (5-CATATT-
GGACAAAAGGCAGGGGAG-3), and Pax3-E4 reverse primer (5-ATG-
TCTCCTGTTCCATCACCCTGC-3).  Total  RNA  isolated  from  MyoD
/ 
myoblasts was used for this RT-PCR. The amplified fragments were cloned into 
pCR2.1-TOPO vector (Invitrogen). The XbaI–SpeI fragment containing the 
Pax3-3UTR from the vector was inserted into 3-XbaI site of the pGL3 control 
vector and the pMX-Pax3 vector. For mutant genes (pLuc-3UTRM and pMX-
Pax3-3UTRM), three separated fragments of the 3UTR were amplified by 
PCR using Pfx polymerase, M13 reverse (5-CAGGAAACAGCTATGAC-3)   
with Pax3-M1R (5-CACACACGGATCCTTTTAGCTTCTTTGATC-3), and   
Pax3-M1F  (5-GATCAAAGAAGCTAAAAGGATCCGTGTGTG-3)  with   
Pax3-M2R (5-AAATCTAAAGGGATCCTATTTGTGCCTACC-3), Pax3-M2F 
(5-GGTAGGCACAAATAGGATCCCTTTAGATTT-3),  and  T7  (5-TAATAC-
GACTCACTATAGGG-3) primers. The Pax3-3UTR fragment was used for 
template DNA. Underlined sequences indicate introduced mutations for 
the M1 miR-1/miR-206–binding site at Pax3-M1F and Pax3-M1R primers 
and for the M2 miR-1/miR-206–binding site at Pax3-M2F and Pax3-M2R 
primers. These three DNA fragments were mixed together and used for 
a second round of PCR using Pfx polymerase. For this PCR, M13 reverse 
and T7 primers were used to generate the Pax3-3UTR with mutations at 
two miR-1/miR-206–binding sites. The amplified fragments were digested 
with XbaI and SpeI and inserted into the 3-XbaI site of the pGL3 con-
trol  and  pMX-Pax3  vectors.  For  the  Bcl-2–Luc  reporter  gene,  genomic 
PCR was performed using Platinum Pfx polymerase, Bcl-2 F1 primer   
(5-CTTCACCCAAGGGTAGCATATTGG-3), and Bcl-2 R1 primer (5-AGCA-
GCTTGCTAAATGCAGGCACG-3) to amplify the 1,178-bp 5-flanking   
region of the mouse Bcl-2 gene. This region is a homologous 5-flanking 
region of the rat Bcl-2 gene used for the Bcl-2–P1-Luc reporter plasmid 
with high Luc activity (Li et al., 2007). Mouse tail DNA was used for the 
template. Amplified fragments were cloned into pCR2.1-TOPO vector. The 
XhoI–SacI fragment containing the Bcl-2 upstream region from this vector 
was inserted into 5-XhoI–SacI sites of the pGL3 basic vector (Promega).
Virus vector infection
A lentivirus vector pCS2-EF-MyoD carrying the EF1 -promoter driving the 
mouse MyoD gene was used for MyoD overexpression experiments as pre-
viously described (Asakura et al., 2007). pMXs and pMX-Pax3 retrovirus 
vectors  were  transfected  into  Plat-E  retrovirus-producing  cells  by  Lipo-
fectamine 2000 following the manufacturer’s instructions. MyoD and Pax3 
expression were assessed by RT-PCR, immunohistochemistry, and Western 
blotting. Adenovirus vectors expressing Cre recombinase and EGFP fusion 
gene (provided by Y. Kawakami) were used for deletion of floxed dicer 
gene in dicer
fl/fl myoblasts. The PCR primers (dicer del forward and re-
verse) described in Fig. S1 were used for detection of dicer gene after Cre 363 Pax3 regulation by MyoD-induced microRNAs • Hirai et al.
of caspase-3 was determined using the CaspACE Assay system (Promega) 
in  accordance  with  the  manufacturer’s  instructions.  The  absorbance  at   
405 nm was determined using a spectrophotometer (Ultrospec 2100 pro; 
GE Healthcare). Experiments were performed within the linear range of the   
assay, and absorbance was normalized by the protein concentration of each 
lysate as determined using the Micro BCA Protein Assay Reagent kit.
ChIP assay
ChIP assay was performed for myoblast cultures using the ChIP assay kit 
following the manufacturer’s instructions (Millipore; Filippova et al., 2001). 
IP was performed overnight at 4°C with anti–RNA polymerase II (Millipore). 
PCR primers, Pax3-IP, Pax7-IP, and Ig heavy chain IP used for this assay are 
described in Fig. S1.
Statistics
All data are expressed as mean ± SEM. Statistical significance between 
groups was analyzed by Student’s t test. At least three independent experi-
ments were performed. Asterisk and double asterisk indicate experimental 
pairs where differences between the compared values were statistically 
significant (P < 0.05 and P < 0.01, respectively).
Online supplemental material
Fig. S1 summarizes the list of primer pairs used for RT-PCR experiments. 
Fig. S2 shows MyoD-dependent apoptosis in myoblasts. Fig. S3 shows 
gene expression of anti- and proapoptotic genes. Fig. S4 shows that the 
ectopic  expression  of  Pax3  suppresses  muscle  differentiation,  whereas 
transfection  of  miR-1/miR-206  enhances  muscle  differentiation.  Fig.  S5   
shows a comparison of QSCs isolated from wild-type and MyoD
/ mice. 
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.201006025/DC1.
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recombinase expression. All protocols were approved by the Institutional 
Biosafety Committee of the University of Minnesota.
Semiquantitative RT-PCR
Total RNA was isolated from cells and tissues by TRIzol (Invitrogen). Puri-
fied RNA was reverse transcribed (Transcriptor First Strand cDNA Synthe-
sis kit; Roche), and 20–35 PCR cycles were performed (thermal cycler; 
Eppendorf) using the gene-specific primer pairs described in Fig. S1. Opti-
mal PCR cycles for each pair were determined by several different amplifi-
cations of the PCR products. Semiquantitative analysis after RT-PCR was 
performed using ImageJ software (National Institutes of Health). Each rela-
tive expression was calculated by internal control -actin gene or 18S ribo-
somal RNA gene expression.
miRNAs
Myoblasts  were  transfected  with  pre-miRNA  negative  control,  pre-hsa– 
miR-1, pre-hsa–miR-206, anti–miR-1, or anti–miR-206 (Applied Biosystems) 
using Lipofectamine 2000 following the manufacturer’s instructions. Trans-
fections were performed three times every day to obtain the maximum 
gene suppression effect. 1 d after the final transfection, total RNA or pro-
tein was isolated for RT-PCR or Western blotting. For differentiation assays, 
1 d after final transfection, cells were treated with differentiation medium 
for an additional 1, 2, or 3 d. For detection of miRNAs, total RNA was 
isolated from cells by TRIzol (Invitrogen). miRNAs were detected by the 
mirVana quantitative RT-PCR miRNA detection kit with mirVana PCR primer 
sets for hsa–miR-1, hsa–miR-15a, hsa–miR-16, hsa–miR-22, hsa–miR-24, 
hsa–miR-27b, hsa–miR-100, hsa–miR-133a, hsa–miR-191, or hsa–miR-206 
in accordance with the manufacturer’s instructions (Applied Biosystems).   
In brief, semiquantitative RT-PCR was performed with miR-specific RT primers 
followed by 20–35 PCR cycles (thermal cycler; Eppendorf). Optimal PCR 
cycles for each pair were determined by several different amplifications 
of the PCR products (90 bp). TargetScan 4.1 algorithm (http://www 
.targetscan.org/vert_40/) was used to identify several miRNAs that are 
predicted to bind to sites on Pax3 mRNA.
Luc reporter assays
The firefly Luc reporter genes pGL3-control, pGL3-basic, pBcl-xL–Luc, pLuc-
Pax3-3UTR, pLuc-Pax3-3UTR-Mut, and pBcl-xL–Luc (pGL3-6-2; provided 
by B.W. Schäfer, University Children’s Hospital Zurich, Zurich, Switzer-
land; Margue et al., 2000) were used in this study. pRL-TK (Promega) was 
used as an internal control. Myoblasts were transfected with pre-miRNAs, 
MyoD  expression  vector  (pcDNA-MyoD),  Pax3  (pcDNA-Pax3)  or  Pax7 
(pcDNA-Pax7), and the Luc reporter genes with Lipofectamine 2000. Cells 
were harvested at 2 d after transfection. Luc activity was measured with a 
plate reader (LD400; Beckman Coulter) using a dual Luc reporter assay 
system (Promega).
Cell fractionation and Western blotting
Mitochondrial  and  cytosolic  proteins  were  isolated  with  ApoAlert  Cell 
Fractionation  kit  (Takara  Bio  Inc.)  following  the  manufacturer’s  recom-
mended protocols. Protein concentration of the fractions was determined 
using the Micro BCA Protein Assay Reagent kit (Thermo Fisher Scientific). 
Cyt c was detected by Western blotting with anti–Cyt c antibody (Takara 
Bio Inc.) followed by anti–rabbit IgG HRP (Cell Signaling Technology).   
To verify equal loading proteins, the same blots were stripped and reprobed   
with anti–-actin antibody (Sigma-Aldrich) as a cytosolic marker or anti–Cyt 
c oxidase subunit IV (COX4) antibody (Takara Bio Inc.) as a mitochondrial 
marker followed by anti–mouse IgG HRP (Bio-Rad Laboratories). Western 
blotting was also performed with anti-MyoD antibody (Ab-1; Thermo Fisher 
Scientific), anti-Pax3 antibody (Developmental Studies Hybridoma Bank), 
anti-Bcl-2 antibody (Ab-4; Thermo Fisher Scientific), anti–Bcl-xL antibody 
(Ab-2; Thermo Fisher Scientific), and anti-Bak antibody (Thermo Fisher 
Scientific). To verify equal loading proteins, the same blots were stripped 
and reprobed with anti–-actin or anti–-tubulin antibody (Sigma-Aldrich).   
The reaction was developed using SuperSignal West Femto chemilumines-
cent substrate (Thermo Fisher Scientific) in accordance with the manufac-
turer’s instructions.
Apoptosis assays
For detection of apoptosis, TUNEL assays were performed after UV expo-
sure, treatment with thapsigargin, or low-serum differentiation conditions 
(DME supplemented with 5% horse serum) using the DeadEnd Colorimetric 
TUNEL system (Promega) in accordance with the manufacturer’s instruc-
tions. For differentiation, myoblasts were cultured in low-serum medium 
without changing medium until 5 d. Dead cell numbers were assessed 
under the microscope after Trypan blue staining (Invitrogen). The activity JCB • VOLUME 191 • NUMBER 2 • 2010   364
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